The diagnostic value of ovarian cystadenocarcinoma with MRI and CT

Objective To discuss the value of clinical application and choice with MRI/CT for diagnosing ovarian serous cystadenocarcinoma and ovarian mucinous cystadenocarcinoma. Methods To analyse 22 cases of ovarian through MRI confirmed by surgicopathology and compare with those of the relevant CT cystadenocarcinoma retrospectively. Results MRI revealed 14/22 cases of ovarian serous cystadenocarcinoma,8/22 cases of ovarian mucinous cystadenocarcinoma, and pathology confirmed 13/14 cases as the serous cystadenocarcinoma,1/14 case as the ovarian seromucinous cystadenoma,5/8 cases for mucinous cystadenocarcinoma. 3/8 cases for mucinous cystadenoma. CT showed 10/20 cases as the serous cystadenocarcinoma, 10/20 cases as the mucinous cystadenocarcinoma, and pathology proved 9/10 cases for serous cystadenocarcinoma, 1/10 case for ovarian clear cell carcinoma, 9/10 cases for mucinous cystadenocarcinoma, 1/10 case for serous cystadenocarcinoma complicated with bleeding. Furthermore, the characteristic or unique features contributed with MRI and CT were comprehended as follows. Both of MRI and CT can demonstrate ovarian cystadenocarcinoma as cystic and consistent mass that means no significant difference in sensitivities. As regards to specificities, plain MRI can unveil more clearly the mass ingredients than those through CT, outcoming with profitable benefit in specificity; but conversely enhanced CT can demonstrate the enhanced regional wall irregularities and nodules while MRI can't do so clearly and precisely due to the presence of higher signal intensities caused by mucin on enhanced MRI. T1WI with intermingling of the paramagnetic substance (GD. DTPA), leading to comparatively lower specificity. Conclusion MRI and CT are nearly equal in application of diagnosing ovarian serous cystadenocarcinoma. But CT is superior to MRI in diagnosing the qualification of ovarian mucinous cystadenocarcinoma.